Drug discovery campaigns are often remembered for the final molecule that reaches the clinic. Less visible—but equally important—is the assay strategy that made the discovery possible. The identification of GDC-8264 by researchers at Genentech revealed a potent and selective RIP1 kinase inhibitor now in Phase 2 clinical development. This provides a clear example of how […]
BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400
info@bellbrooklabs.com